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Abstract
Background: Several facultative anaerobic bacteria with potential therapeutic abilities are known to preferentially colonize
solid tumors after systemic administration. How they efficiently find and invade the tumors is still unclear. However, this is
an important issue to be clarified when bacteria should be tailored for application in cancer therapy.
Methodology/Principal Findings: We describe the initial events of colonization of an ectopic transplantable tumor by
Salmonella enterica serovar Typhimurium. Initially, after intravenous administration, bacteria were found in blood, spleen,
and liver. Low numbers were also detected in tumors associated with blood vessels as could be observed by
immunohistochemistry. A rapid increase of TNF-a in blood was observed at that time, in addition to other pro-inflammatory
cytokines. This induced a tremendous influx of blood into the tumors by vascular disruption that could be visualized in H&E
stainings and quantified by hemoglobin measurements of tumor homogenate. Most likely, together with the blood,
bacteria were flushed into the tumor. In addition, blood influx was followed by necrosis formation, bacterial growth, and
infiltration of neutrophilic granulocytes. Depletion of TNF-a retarded blood influx and delayed bacterial tumor-colonization.
Conclusion: Our findings emphasize similarities between Gram-negative tumor-colonizing bacteria and tumor vascular
disrupting agents and show the involvement of TNF-a in the initial phase of tumor-colonization by bacteria.
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Introduction
Bacteria and bacterial products have been investigated as
therapeutic agents to treat solid tumors for more than 100 years
[1–3]. In this context, several bacterial species have been
discovered that selectively accumulate and replicate in solid
tumors [4–8]. As reason was suggested that such bacteria find
favorable niches within the hypoxic and necrotic regions of the
tumor. Accordingly, tumor-colonizing bacteria are either obligate
or facultative anaerobic.
Presently, tumor-colonizing bacteria have attracted sincere
investigative interest due to their obvious therapeutic potential.
The use of viable migratory bacteria that bear intrinsic or
engineered tumor therapeutic effectors might circumvent several
problems encountered with conventional tumor therapies. For
instance, due to the irregularly developed vasculature the
accessibility of some tumor regions for chemotherapeutics might
be reduced. Thus, the tumor is not affected completely and is able
to continue to grow. Similarly, hypoxic regions as often found in
solid tumors, pose problems for ionizing irradiation therapy since
oxygen is required for its effectiveness. Bacteria that thrive under
anaerobic conditions would not be limited by this.
Alternatively, isolated microbe-associated molecular patterns
(MAMPs) have been investigated to activate the immune system
against the cancer are thus limited [9–11]. Some success has been
observed. However, viable bacteria have several advantages
compared to such ‘‘passive molecules’’ and are therefore able to
colonize the tumor and actively destroy it at least in part. In
addition, tumor colonization and therapeutic properties of
bacteria can be improved either by selection or genetic
engineering [4,12,13].
Various bacteria have been shown to be usable for bacteria-
mediated tumor therapy [14]. For instance, spores of Gram-
positive Clostridia spp. that exclusively germinate in necrotic parts
of tumors have been employed alone or in combination with
radio- and chemotherapy for treatment of experimental tumors
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Typhimurium (S. Typhimurium) as well as Escherichia coli (E. coli)
strains have been studied. Thus, a highly attenuated S.
Typhimurium strain VNP20009 was established and tested in
animal models. Importantly, this strain was found to be safe in first
clinical trials [20,21]. However, the outcome of such trials was
rather disillusioning despite the success in experimental models
[22–24]. Only very high doses or continuous administration of
VNP20009 led to tumor colonization. Therapeutic effects were
rare [20,21]. Nevertheless, these first clinical trials showed the
general applicability of bacteria in cancer therapy. However, they
also made clear that it is essential to understand more about the
interactions between tumor-bearing host and bacteria in order to
render bacteria safe and efficient.
Presently, the major drawback regarding bacterial tumor therapy
is the insufficient knowledge about bacterial entry into the tumor.
Consistently, Salmonella were shown to adhere to walls of blood
vessels at low flow rates [25] and to be attracted to necrotic areas of
in vitro tumors [26]. This suggested the production of chemotactic
compounds by quiescent or dead cancer cells inside solid tumors.
Once in the tumor, E. coli for instance altered the tumor
microenvironment in murine breasttumors by vascular remodeling,
focal concentration of tumor associated macrophages and focal
expression of MMP-9 and TNF-a around bacterial colonies [27].
In our own studies, we observed a massive infiltration of
CD11b
+Gr1
+ host neutrophilic granulocytes into ectopic colon
carcinomas after infection with different Gram-negative facultative
anaerobic bacteria [28]. Such host cells formed a barrier
restricting bacteria to necrotic areas and prohibited bacterial
spread within the tumor. Importantly, bacterial colonization
clearly led to a severe enhancement of necrosis [28].
In the present study we investigated the initial events of tumor
colonization by S. Typhimurium SL7207 to obtain insights into
the mechanism of tumor entry. As early as 30 min post infection
(p.i.) first bacteria were observed in tumor tissue. In parallel high
concentrations of TNF-a could be found in blood and a
tremendous influx of blood into the tumor was observed at that
time. This was followed by necrosis formation, bacterial growth,
and neutrophil-infiltration into the tumor. Our observations
indicate that tumor-colonizing Salmonellae provoke effects in tumor
blood vessels that resemble vascular disrupting agents (VDAs) or
TNF-a. Our data further suggest that TNF-a in concert with other
pro-inflammatory cytokines plays an important role in efficient
bacterial tumor colonization. As this study presents essential first
findings on how Salmonella enter tumors, it represents an
important basis for further investigations required to render
Salmonella effective and safe for clinical application in cancer
therapy.
Materials and Methods
Ethics statement
All animal experiments were performed according to local
guidelines from LAVES (Niedersaechsisches Landesamt fu ¨r
Verbraucherschutz und Lebensmittelsicherheit).
Bacterial strains and growth conditions
The S. Typhimurium strain SL7207 (hisG, DaroA) was kindly
provided by Bruce Stocker [29] and E. coli TOP10 was purchased
from Invitrogen. Both bacterial strains were grown in LB medium.
Cell lines and animals
BALB/c mice were purchased from Harlan (Borchem). CT26
colon carcinoma cells (ATCC CRL-2638) were grown as
monolayers in IMDM Medium (Gibco BRL, Germany) supple-
mented with 10% (v/v) heat-inactivated fetal calf serum (Integro),
250 mmol/l b-Mercaptoethanol (Serva) and 1% (v/v) penicillin/
streptomycin (Sigma-Aldrich, Germany).
Infection of tumor bearing mice and recovery of bacteria
from tissues and blood
Six week old, female BALB/c mice were subcutaneously
inoculated at the abdomen with 5610
5 CT26 cells. Mice bearing
tumors of approximately 4–7 mm diameter were intravenously
injected with 5610
6 CFU of S. Typhimurium suspended in
phosphate-buffered saline (PBS). At different time points p.i. mice
were sacrificed and their tumors and spleens were transferred into
1 ml of sterile ice-cold PBS containing 0.1% (v/v) Triton X-100,
livers were transferred into 2 ml of this solution. Tissues were
homogenized by using a Polytron PT3000 homogenizer (Kine-
matica). In addition, heart blood was taken after sacrifice and
diluted 1:2 with 0.1% (v/v) Triton X-100. For determination of
total CFU per organ, homogenates were serially diluted in PBS
and plated with the required antibiotics on LB plates. Tumors
were additionally weighed to calculate the total CFU per gram
tumor tissue.
Non-invasive in vivo imaging of luminescent Salmonella
An S. Typhimurium strain expressing the luxCDABE operon of
Photorhabdus luminescens under the control of the b-Lactamase
promoter was used to visualize the bacterial dissemination in the
living animal with the help of the IVIS200 system (Calipers). Prior
to analysis, mice were anaesthetized with 2% isoflurane using
XGI-8 gas anesthesia system (Calipers). Pseudocolored images of
photon counts and photographic images were obtained according
to instructions of the manufacturer. The software Living Image 2.5
(Calipers) was used for image analysis.
Determination of Hemoglobin content in tumors
Tumors were removed and homogenized in 1 ml ice-cold sterile
PBS. To lyse erythrocytes 500 ml ACK lysing Buffer were added to
the homogenate and incubated for 10 minutes at room
temperature. Subsequently, the samples were centrifuged at
13,000 rpm for 10 minutes and 300 ml of the supernatants were
mixed with 1 ml Drabkin’s reagent (Sigma-Aldrich). After 30 min
of incubation the optical density at 540 nm was measured.
Determination of TNF-a in serum
TNF-a biological activity in serum was determined using TNF
sensitive L929 fibroblasts. In brief: 4610
4 cells were seeded in 96-
well plates and incubated over night. The following day the
medium was replaced with 100 ml complete IMDM including the
samples of interest and actinomycin D [6.25 mg/ml] (Sigma-
Aldrich). 50 ml of TNF-a standard [1 ng/ml] (CHEMICON) as a
reference and 15 ml of serum samples were added in duplicates to
the cells and serial dilutions were performed. After 18 hours of
incubation, cell supernatants were replaced with 100 ml complete
IMDM and cell viability was determined using the EZ4U KIT
(BIOMEDICA). TNF-a concentrations were defined by compar-
ing the L929 killing induced by the serum samples, with the killing
induced by dilutions of TNF-a of known concentrations.
RT-PCR of Salmonella-infected CT26 cells and
subcutaneous CT26-tumors
For in vitro experiments, CT26 cells were infected with S.
Typhimurium SL7207 for 30 min before changing antibiotic-free
IMDM medium to IMDM medium containing 50 mg/ml
S. Typhimurium Entering Tumors
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and RNA was isolated using RNAeasy Mini Kit according to the
manufacturer’s protocol (Qiagen). Reverse transcription was
carried out using Revert Aid First Strand cDNA Synthesis kit
(MBI Fermentas). For in vivo experiments, BALB/c mice bearing
subcutaneous CT26-tumors were intravenously infected with
5610
6 SL7207. At different time points after infection tumors
were removed and homogenized in RNAprotect (Qiagen). After
centrifuging the homogenate for 5 min at 13 000 rpm the
supernatant was used to isolate RNA and reverse transcription
was performed as described above. Semi-quantitative PCRs were
performed using primers; 59-TCT CAT CAG TTC TAT GGC
CC-39,5 9-GGG AGT AGA CAA GGT ACA-3 .9 for TNF-a
(amplifying a fragment of 212 bp) and 59-CTG GAC GAG GGC
AAG ATG AAG C-39,5 9-TGA CGT TGG CGG ATG AGC
ACA-3 .9 for ribosomal protein S9 (RPS9). Amplification conditions
were: denaturation at 94uC for 1 min followed by 27 and 32 cycles
(for RPS9 and TNF-a), respectively, of repeated denaturation
(20 s at 94uC), annealing (20 s at 58uC) and extension (20 s at
72uC). PCR products were analyzed on a 2% agarose gel. Equal
amounts of cDNA were applied according to intensity of the
amplification product of RPS9.
Determination of proinflammatory cytokines and
chemokines in serum
Cytokines were quantified using a cytometric bead array (CBA)
mouse inflammation kit from BD Bioscience. For the assay, 50 ml
of PE detection reagent were added to 50 ml of mixed solution of
IL-6, IL-10, MCP-1, IFN-c, TNF-a and IL-12(p70) detection
beads. A volume of 50 ml of each sample was transferred to the
appropriate assay tubes containing mixed capture beads and PE
detection reagent. The assay tubes were incubated protected from
light for 2 h at RT. A volume of 1 ml of wash buffer was added
and the tubes were centrifuged at 2006g for 5 minutes. The
supernatant was discarded and the samples were resuspended in
300 ml of wash buffer. The acquisition was performed in a
FACSCalibur (BD Bioscience) using the CBA software. Standard
curves were plotted in each experiment for all of the analyzed
cytokines.
TNF-a studies
Six week old, female BALB/c mice were subcutaneously
inoculated at the abdomen with 5610
5 cells of the colon
adenocarcinoma cell line CT26. Ten days after injection of tumor
cells one group of mice was treated i.v. with graded amounts of
recombinant TNF-a (less than 0.1 ng endotoxin per mg TNF-a;
Chemicon) and the second group received graded amounts of
TNF-a directly applied into the tumor (i.t.). Anti-TNF-a treatment
was carried out as follows: tumor-bearing mice were injected i.v.
with either 250 mg rat anti-TNF-a (clone TN3-19.12, BioLegend)
or 200 mg of rat anti-mouse TNF-a (Clone V1qH8 [30]) or
normal rat IgG as control 20 min before an i.v. injection of
5610
6 CFU of S. Typhimurium. Tumors were photographed at
different time points p.i., analyzed histologically, used for CFU
determination, and for determination of hemoglobin content,
respectively.
Histology
Tumors were removed from sacrificed mice and snap-frozen in
Tissue-Tek OCT Compound (Sakura Finetek). Cryosections of
10 mm were cut with a microtome-cryostat and placed onto glass
slides. Slides were air dried at room temperature overnight and
fixed in acetone at 220uC for 3 min. Slides were rehydrated in
PBS, blocked with 50 mg/ml BSA and 1 mg/ml FcR blocker (rat
anti-mouse CD16/CD32), and stained with the following
reagents: polyclonal rabbit anti-S. Typhimurium (USBiological),
polyclonal goat anti-rabbit Alexa 488 (Sigma-Aldrich), rat anti-
Gr1 biotin (RB6-8C5 – Ly6G-specific, eBioscience), Streptavidin-
Cy5 (Invitrogen), rat anti-CD31 PE (eBioscience). After staining,
the slides were washed, dried, mounted with mounting medium
(Neomount, Merck) and analyzed using a laser scanning confocal
microscope (LSM 510 META, Zeiss). Images were processed with
LSM5 Image Browser (Zeiss) and Adobe Photoshop 7.0. For
paraffin sections, tumors were fixed in 10% (v/v) paraformalde-
hyde and embedded in paraffin wax. 5 mm sections were mounted
on slides and stained with hematoxilin and eosin (HE). The stained
paraffin sections were analyzed with an Olympus BX51
microscope and pictures were taken with an Olympus U-CMAD3
camera.
Statistical analysis
Statistical analysis were performed using the two-tailed
Student’s t-test with P,0,05 considered as significant.
Results
Tumor colonization of S. Typhimurium SL7207 within the
first 24 h post infection
Although it is well known that several bacterial strains are able to
colonize solid tumors and exert potential anti-tumoricidal effects,
the mechanism by which bacteria enter tumors is not clear so far. As
this knowledge is essential to render bacteria safe and efficient for
anti-cancer therapy we investigated the early time points after
systemic Salmonella administration in a murine tumor model. To
this end, BALB/c mice bearing the commonly used murine colon
carcinoma CT26 were infected i.v. (intravenously) with 5610
6 S.
Typhimurium SL7207 a strain that is widely used as carrier for
vaccine experiments. At different time points p.i. (post infection),
colony forming units (CFU) in blood, tumor, and spleen were
determined (Fig. 1a). In blood, bacterial numbers quickly decreased
within the first 6 h p.i. but then remained constant until the end of
the observation period. In spleen, the number of Salmonellae reached
a plateau already at 2 h p.i. and showed only minor variations over
the observation period. In tumors, bacterial numbers increased
constantly from 2 h to 48 h p.i. most likely due to proliferation.
This course of colonization was corroborated by non-invasive in
vivo imaging using S. Typhimurium equipped with the lux operon
of Photorhabdus luminescens. Bio-luminescence distributed over the
entire body could be observed immediately after i.v. administra-
tion. However, already 20 min p.i. significantly increased
luminescence was detectable in spleen and liver indicating
colonization (Fig. 1b arrows). Colonization of the subcutaneous
tumors located at the lower abdomen of the mice became
apparent later. By 24 h p.i. the signal obtained from tumors
(arrow) was by far exceeding the signal from spleen and liver as
bacteria were accumulating in high numbers at the tumor site
(Fig. 1b).
To obtain a more detailed insight into initiation of tumor
colonization, we refrained to histological analysis. Cryosections of
tumors from various time points were stained with fluorescence-
conjugated antibodies against Salmonellae, neutrophilic granulo-
cytes (CD11b
+Gr1
+) and CD31, a molecule found on endothelial
cells to highlight distribution and course of blood vessels. Single
bacteria could be found inside blood vessels of CT26 tumors
30 min p.i. (Fig. 1c, 30 min). Interestingly, some bacteria had
already escaped from such vessels. This did not change
significantly over the first 6 h p.i.. Most of bacteria were single
S. Typhimurium Entering Tumors
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small clusters or colonies of Salmonellae were detected (Fig. 1c 6 h
p.i.). Such clusters were observable more frequently at 12 h p.i.
(data not shown) and they were distributed over the entire tumor
although mostly the bacterial colonies were still in close contact to
blood vessels. By 15 h p.i. the scattered bacterial colonies had
become considerably larger (Fig. 1c, 15 h p.i.) and single bacteria
began to localize distantly from blood vessels. By 18 h p.i. this
‘‘initial phase’’ concluded (Fig. 1c, 18 h p.i.). The distribution of
bacteria and immigrated Gr1
+ host neutrophils now resembled the
situation that was described for 48 h and later [28].
Low magnification overviews of colonized CT26 tumors
revealed immigration and distribution of host neutrophils
(Fig. 1d). At early time points p.i. Gr1
+ cells were distributed in
low numbers over the entire tumor with a slight accumulation at
the tumor rim. The formation of bacterial colonies and the
dissemination of bacteria within the tumor correlated with a strong
influx of neutrophils between 12 h and 15 h p.i.. By 18 h p.i. a
small barrier of neutrophils had formed that apparently shielded
the vital tumor tissue from the now quickly multiplying Salmonellae.
The basic pattern of a neutrophil barrier surrounding the bacteria-
colonized necrosis, which we had reported for two days p.i. [28],
could already be seen after 18 h p.i., albeit less pronounced.
Taken together: After i.v. application of S. Typhimurium into
tumor bearing mice bacteria very quickly accumulate in spleen
and liver while solid tumors are colonized only by limited numbers
Figure 1. Time course of bacterial accumulation in different organs and bacterial colonization of solid CT26 tumors. Tumor bearing
mice were infected i.v. with S. Typhimurium SL7207. (a) 2 h, 6 h, 12 h, 24 h and 48 h p.i. tumor and spleen were homogenized. Tumor, spleen and
blood were plated and the CFUs per total organ were determined. (b) Non-invasive in vivo imaging of bacterial bioluminescence. Tumor-bearing mice
were infected with S. Typhimurium expressing the luxCDABE operon of Photorhabdus luminescens under the control of the b-Lactamase promoter.
Arrows show sites of high bacterial accumulation. Images were taken at the indicated time points. (c) High magnification images of tumor
cryosections at the indicated time points p.i. with S. Typhimurium SL7207. In all pictures, bacteria are stained in green, blood vessel endothelial cells
are stained in blue and neutrophilic granulocytes are stained in red. White arrows point at individual Salmonella. White bars correspond to 10 mmi n
all pictures. (d) Overviews of CT26 tumor cryosections at the indicated time points p.i. with S. Typhimurium SL7207. Stainings are described in (c).
White bars correspond to 100 mm in all pictures. Experiments were repeated at least three times with identical results.
doi:10.1371/journal.pone.0006692.g001
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the normal target organs remain rather constant. In contrast,
numbers in the tumor dramatically increase during this period
most likely due to proliferation. This is accompanied by a strong
influx of host neutrophils.
Bacterial colonization of solid tumors is accompanied by
hemorrhage
A first hint on the mechanism of tumor colonization by S.
Typhimurium came from macroscopic observations. Between 6 h
and 15 h p.i., tumors became dark red indicating strong blood
influx (Fig. 2a), which started to resolve at about 24 h p.i.. To
investigate this phenomenon in more detail, we analyzed HE-
stained paraffin sections (Fig. 2b) and found high numbers of
erythrocytes (indicated by stars) at various places of the tumor at
6 h p.i.. Between 9 h and 15 h p.i. erythrocytes inside the tumor
disintegrated. The complete tumor center that contained disinte-
grating erythrocytes became necrotic (indicated by ‘‘N’’) as can be
seen by the purple staining in Fig. 2B (15 h–24 h). The outer rim
of the tumors remained vital (indicated by ‘‘V’’). In accordance
with the cryosections (Fig. 1c and d), neutrophils infiltrated the
tumors between 18 h and 24 h p.i. and settled at the transition
between viable and necrotic tumor regions (arrows point at
exemplary neutrophils).
To independently confirm these observations, the hemoglobin
content in CT26 tumors after infection with Salmonellae was
determined (Fig. 2c). This should be directly correlated with influx
of blood. Strong increases of hemoglobin between 2 h and 12 h
p.i. were observed confirming an accumulation of blood in the
tumors. After 12 h p.i. the hemoglobin content in the tumors
decreased, pointing at disintegration and decomposition of the
infiltrated erythrocytes.
These observations suggested that shortly after i.v. administra-
tion of Salmonellae to tumor-bearing mice a severe hemorrhage is
induced inside the tumors that might flush in blood-borne
bacteria. Upon resolution, a large necrotic area is left behind in
which bacteria reside and thrive, and which is enclosed by host
neutrophils.
Induction of high concentrations of TNF-a upon
administration of S. Typhimurium
The strong hemorrhage of tumors and the subsequent
infiltration of neutrophils suggested the induction of blood
vessel-disrupting, neutrophil-attracting factors by the infected solid
tumors. One cytokine that is known to promote such phenomena
is TNF-a [31]. However, neither RT-PCRs from Salmonella-
infected CT26 cells in vitro, nor RT-PCRs from Salmonella-infected
CT26 tumors in vivo showed expression of TNF-a by CT26 cells or
immune cells residing in CT26 tumors (Fig. 3a). Nevertheless, in
blood we could detect TNF-a shortly after administration of
bacteria (Fig. 3b). Here, TNF-a levels peaked between 30 min and
2 h p.i. and reached background levels again by 4 h p.i..
Systemic administration of TNF-a leads to hemorrhage in
tumors
To test whether TNF-a in blood could be responsible for
hemorrhage of CT26 tumors, graded concentrations of murine
TNF-a were injected i.v. or i.t. (intratumorally) into tumor-bearing
mice. Indeed, even the lowest amount of TNF-a injected, which
was not detectable in the blood of the animals upon injection (data
not shown), was sufficient to induce influx of blood into the tumors
(Fig. 4a and 4b). HE-stained paraffin sections confirmed the
presence of high numbers of erythrocytes (indicated by stars) inside
tumors by 6 h post injection (Fig. 4b), similar to the observations
made after administration of S. Typhimurium. Large amounts of
erythrocytes could be observed in all samples from treated mice.
Tumor tissue exposed to hemorrhage is apparently becoming
necrotic (indicated by ‘‘N). Since the recombinant TNF-a was
essentially free of endotoxin, hemorrhage was obviously induced
exclusively by this cytokine.
Determination of hemoglobin content in CT26 tumors after i.v.
injection of 200 mg TNF-a into tumor bearing mice confirmed
these results (Fig. 4c). Actually, the kinetics of blood influx closely
resembled that observed when bacteria were administered i.v.. A
quick rise by 6 h to 12 h and resolution by 24 h post application
was observed. Thus, TNF-a per se is able to induce a similar
hemorrhage in CT26 tumors as i.v.-injected Salmonellae. Interest-
ingly, the extend of blood influx induced by TNF-a was lower than
the influx observed after bacterial infection. This might suggest the
involvement of additional mechanisms induced by the microor-
ganisms.
Depletion of TNF-a retards blood influx and bacterial
tumor colonization
We then wanted to test whether TNF-a is the sole cytokine
responsible for the blood influx and bacterial colonization of solid
tumors. Therefore, we neutralized TNF-a by injecting rat anti-
mouseTNF-a i.v. 20 min before infection. As intended, the
majority of TNF-a in blood was neutralized this way (Fig. 5a).
The consequence was a retardation of blood influx into the tumor
(Fig. 5b). While tumors from Salmonella-infected mice became
dark red within 2 h p.i., tumors of anti-TNF-a treated mice began
to show this phenomenon between 4 and 6 h p.i.. No resolution of
blood influx became apparent within 30 h p.i..
These observations were in agreement with hemoglobin content
in tumors of both groups of mice (Fig. 5c). While in Salmonella-
infected mice the hemoglobin content in tumors quickly increased
to a maximum between 6 h and 12 h p.i. and quickly decreased
thereafter, the hemoglobin content in tumors of anti-TNF-a-
treated, Salmonella-infected mice increased more slowly and did
not decrease within the observation period.
Finally, the bacterial tumor-colonization from both groups was
determined by plating tumor homogenates (Fig. 5d). While
Salmonellae quickly accumulated and grew in CT26 tumors, tumor
colonization after treatment with anti-TNF-a was slightly delayed.
12 h p.i. around 5610
6 bacteria/g tumor were found in tumors of
Salmonella-infected mice, but only around 7610
5 bacteria/g
tumor were found in infected mice that were treated with anti-
TNF-a. At later time points, bacterial numbers in tumors of both
groups became similar. Thus, a severe diminution of TNF-a can
delay tumor colonization by S. Typhimurium but does not abolish
it. These data indicate that either minimal amounts of TNF-a are
sufficient to induce blood influx and support bacterial tumor
colonization or that the absence of TNF-a can be compensated by
other factors that are induced during a bacterial infection.
Expression of multiple cytokines in serum shortly after i.v.
administration of S. Typhimurium
Since depletion of TNF-a after i.v. administration of S.
Typhimurium did not inhibit blood influx and bacterial tumor
colonization completely, we suspected other pro-inflammatory
cytokines to additionally support efficient bacterial tumor-
colonization. Thus, we analyzed blood from infected and
uninfected mice shortly after infection for selected cytokines
(Fig. 6). As expected, several proinflammatory cytokines and
chemokines such as IL-6 and MCP-1 are highly up-regulated by
S. Typhimurium Entering Tumors
PLoS ONE | www.plosone.org 5 August 2009 | Volume 4 | Issue 8 | e6692Figure 2. Time course of blood influx into CT26 tumors after bacterial infection. (a) Photographs of CT26 tumors at different time points
p.i. with S. Typhimurium. (a left) Photographs of the fur side of the tumors. (a right) Photographs of the ventral side of the tumors. (b) HE-stained
paraffin sections of CT26 tumors at different time points p.i. with S. Typhimurium. (b left) Low magnification overviews. (b right) Higher
magnifications of the tumors shown in (b left). 6 h–12 h: High magnifications of erythrocyte-containing (stars) central tumor areas. 15 h–24 h: High
magnifications of the transition between developing necrosis (N) and remaining vital tumor rim (V). Arrows point exemplarily at neutrophils. Black
bars correspond to 500 mm in (b left) and 100 mm in (b right). (c) Hemoglobin content in CT26 tumors at different time points p.i. with S.
Typhimurium. Bars show standard deviations of means. Experiments were repeated three times with identical results.
doi:10.1371/journal.pone.0006692.g002
S. Typhimurium Entering Tumors
PLoS ONE | www.plosone.org 6 August 2009 | Volume 4 | Issue 8 | e66922 h p.i.. Interestingly, the secretion pattern of IL-6 resembles the
pattern of TNF-a, while MCP-1 and IL-12 plateaued later. A
fourth mediator, IFNc was up-regulated only 6 h p.i.. Interest-
ingly, IL-10 an anti-inflammatory cytokine was also induced with
an early rise.
Taken together, TNF-a is an important and effective factor in
the initial phase of bacterial tumor-colonization, but it is probably
not the only cytokine that is involved in bacterial entry into solid
tumors.
Discussion
Salmonellae have been tested systematically in experimental
tumor therapies for more than 10 years now [3]. However, little is
known about the mechanisms that are involved in bacterial tumor-
colonization, i.e. how Salmonellae escape from circulation into the
tumor and which factors are involved.
The present work investigates initial events of tumor-coloniza-
tion by attenuated S. Typhimurium SL7207. Bacteria can be
detected histologically in blood vessels of CT26 tumors already
between 30 min to 2 h after systemic administration. In rare cases,
they are found inside tumor tissue but still in close proximity to
blood vessels.
Tumor blood vessels are structurally irregular and leaky, with
irregular diameters and abnormal branching patterns [32,33].
They exhibit a defective cellular lining composed of disorganized,
loosely connected, branched or overlapping endothelial cells [34].
The openings between such disorganized cells do not only
contribute to leakiness of blood vessels in tumors but also permit
access of macromolecules to the tumor tissue. The size of these
openings ranges between 200 and 2000 nm [34]. By extrapolation,
it can be assumed that bacteria can also access tumors via such
openings. Thus, escape of single bacteria from the blood stream
into tumor tissue could be passive or active. In a passive escape
scenario, bacteria would enter the tumor via the described
openings by coincidence. In an active scenario they would actively
seek the openings due to chemotaxis [26]. Also, a combination of
both scenarios appears plausible.
Shortly after the escape of single bacteria into tumor tissue,
invaded bacteria apparently proliferate. By 6 h p.i. micro-colonies
can be found in the vicinity of blood vessels which become larger
as time proceeds. By 15 h p.i. bacteria start to disseminate
throughout the tumor. This initial phase is accompanied by a
strong influx of blood into the tumor.
It was assumed that the bacterial infection induces the
expression and secretion of cytokines in the tumor. A prime
candidate was TNF-a, which is known to act as a vasoactive agent
by modifying the actin cytoskeleton and increasing the perme-
ability of the endothelial lining of blood vessels [31]. Contrary to
our original expectation, TNF-a expression was neither detectable
in infected tumor cells nor in colonized tumors. Instead, TNF-a
was detectable between 30 min to 2 h p.i. at high concentrations
in blood of infected tumor-bearing mice. The cells responsible for
production of TNF-a could not be indentified thus far. According
to the colonization data, the source of TNF-a could be infected
cells of spleen or liver. Blood cells could also be responsible,
although most blood-borne bacteria were not associated with cells
(data not shown). In any case, TNF-a found in serum at 30 min is
most likely derived from cells with pre-stored pools of this cytokine.
Novel bio-synthesis should not be possible within such a short
period of time but could account for TNF-a at the later time
points.
TNF-a induced by intravenously administered Salmonella could
apparently account for the initiation of blood influx into the
tumors since we could show that TNF-a alone is sufficient for this
reaction. However, depletion of TNF-a by antibodies had only a
partial effect on blood influx and bacterial tumor-colonization.
Our finding that several additional cytokines were detected in
blood simultaneously with TNF-a might be the explanation.
However, despite the presence of antibodies, residual free active
TNF-a cannot entirely be excluded to be a possible reason for the
remaining hemorrhage since extremely small amounts suffice to
induce blood influx into tumors.
On the other hand, it is not surprising that intravenous
application of Gram-negative bacteria activates a cascade of pro-
inflammatory cytokines in the host that may account, in addition,
for the induction of other effector molecules observed during
bacterial colonization of tumors like MMP9 etc. [27]. For further
improvement of bacterial tumor therapy it might be required to
obtain a global picture of the events during the tumor invasion by
applying genomics based approaches. In addition, it might be
required to assess the role of every single cytokine and molecule
induced under these conditions by employing appropriate knock
out mice.
Figure 3. TNF-a release into the blood of S. Typhimurium-infected, CT26 tumor-bearing mice. (a) RT-PCRs were performed with RNA
isolated from S. Typhimurium-infected CT26 cells (in vitro) and from CT26 tumors of S. Typhimurium-infected, tumor-bearing BALB/c mice (in vivo)a t
the indicated time points. The amplification product has a size of 212 bp. (b) TNF-a concentration in the blood of CT26 tumor-bearing BALB/c mice at
different times p.i. determined using TNF sensitive L929 fibroblasts. Error bars show standard deviations of means. Results are representative for at
least two independent experiments with 3–5 mice per group.
doi:10.1371/journal.pone.0006692.g003
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cytokines induced after systemic administration of Salmonellae is an
essential reaction for efficient bacterial invasion of tumors. Thus,
attenuation of Salmonellae might render the bacteria safe with
respect to sepsis. On the other hand this might be achieved at the
expense of invasion efficiency.
First clinical trials were carried out with the highly attenuated
Salmonella strain VNP20009 that induces 10.000-fold less TNF-a
in human peripheral blood cells [20]. The low efficiency of tumor-
colonization observed in patients might be due to an over-
attenuation that might not only affect the induction of TNF-a but
the inflammatory response in general. This is an important point
that urgently needs clarification.
Other attempts have been made to improve Salmonella by special
attenuations. For example, a genetically-modified Salmonella Typhi-
murium strain that is auxotrophic for the amino acids arginine and
leucine has been used in several studies showing strong tumor
colonization while liver and spleen are cleared rapidly [4]. After
reisolation from a tumor this auxotrophic strain showed colonization of
not only necrotic but also viable tumor regions and was able to induce
Figure 4. Blood influx into CT26 tumors after treatment with TNF-a. CT26 tumor-bearing BALB/c mice were treated i.v. or i.t. with the
indicated amounts of recombinant TNF-a. Photographs were taken and histology was performed 6 h post treatment. (a) Photographs of tumors of
differently treated mice. (a left) Photographs of the fur side of the tumors. (a right) Photographs of the internal side of the tumors. (b) HE-stained
paraffin sections of the tumors shown in (a). The black bars correspond to 200 mm in the 106magnification pictures, to 100 mm in the
206magnification pictures and to 50 mm in the 406magnification pictures. (N) stands for necrotic region, the stars show accumulations of
erythrocytes.(c) Hemoglobin content in CT26 tumors of BALB/c mice after injection of 200 ng TNF-a i.v.. Results are representative for at least two
independent experiments with 3–5 mice per group.
doi:10.1371/journal.pone.0006692.g004
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As this strain showed a great potential in the model systems used so far,
it is of special interest to see its behavior in immunocompetent mice.
Another issue of this work addresses the establishment of
necrotic regions and development of a viable tumor rim in solid
tumors after bacterial colonization. Whenever analyzing bacteria-
colonized tumors, bacteria were mainly restricted to necrotic
regions, while an outer rim of viable tumor cells invariably persists
[25,28]. The large, bacteria-colonized necrosis is likely a result of
the infection-induced hemorrhage in the tumor. Tissue in vicinity
of hemorrhage becomes necrotic as can be seen in HE-stained
paraffin sections between 9 h and 15 h p.i..
A second cause of the emerging necrosis could be the
disintegration of blood vessels in the hemorrhagic region resulting
in collapse of blood flow. As a result, the constant supply of tumor
cells with nutrients and oxygen ceases. Thus, the tumor cells in the
center of the tumor are ‘‘starved and suffocated to death’’. In
contrast, the viable rim consists of the tumor tissue that was not in
contact with inflowing blood and therefore is still supplied with
nutrients and oxygen.
Interestingly, the same phenomenon of formation of necrotic
regions and a viable tumor rim was reported for solid tumors that
were treated with VDAs [38–40]. Tumor center and periphery can
exhibitdifferentinterstitialbloodpressureandvasculararchitecture.
Thus, tumor periphery might be less sensitive to vascular shutdown
than the center. As the interstitial blood pressure rises strongly from
tumor periphery to tumor center, an increase in vascular
permeability might be catastrophic in the center, while it is
Figure 5. Inhibition of TNF-a in S. Typhimurium-infected BALB/c mice retards blood influx into tumors and bacterial colonization.
(a) TNF-a concentration in the blood of S. Typhimurium-infected, CT26 tumor-bearing BALB/c mice (black bars) and of S. Typhimurium-infected, anti-
TNF-a treated, CT26 tumor-bearing BALB/c mice (grey bars). Error bars show standard deviations of means. (b) Photographs of CT26 tumors of an S.
Typhimurium-infected tumor (left set of pictures) and an S. Typhimurium-infected, anti-TNF-a treated tumor (right set of pictures). The left column of
each set of pictures show the fur side of the tumors, the right pictures show the ventral side of the tumors. (c) Hemoglobin content in CT26 tumors of
S. Typhimurium-infected BALB/c mice (black bars) and S. Typhimurium-infected, anti-TNF-a treated BALB/c mice (grey bars). Error bars show standard
deviations of means. (*) At 6 h p.i. the difference of hemoglobin content in the tumors is significant with p,0.05. (d) Bacterial number per g tumor
tissue in S. Typhimurium-infected tumor-bearing BALB/c mice (black bars) and S. Typhimurium-infected, anti-TNF-a treated tumor-bearing BALB/c
mice (grey bars). Error bars show standard deviations of means. (*) At 12 h p.i. the difference of bacterial numbers between differently treated tumors
is significant with p,0.05. Results are representative for at least two independent experiments with 3–5 mice per group. The second experiment also
included an isotype control where normal rat IgG was injected into the mice of the control group (data not shown).
doi:10.1371/journal.pone.0006692.g005
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tumor periphery is usually higher compared to the center. In case of
extensive vascular damage, residual blood flow is likely to persist in
the tumor periphery, but less likely in the tumor [39].
Having shown the involvement of TNF-a acting as a VDA in
the initial phase of tumor colonization by S. Typhimurium, the
similarity between VDAs and tumor-targeting bacteria in
experimental tumor therapies becomes comprehensible. Although
the increase in vessel permeability is induced differently in both
therapies, the outcome is similar.
Taken together our results show that TNF-a among other pro-
inflammatory cytokines plays an important role in the early phase
of bacterial tumor-colonization. They further indicate that an
initial modification of the observed ‘‘concert of proinflammatory
cytokines’’ can adversely affect the efficiency of bacterial tumor
colonization.
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